Editas Medicine News

Editas Medicine | 8-K: Editas Medicine Announces First Quarter 2024 Results and Business Updates

May 8 19:13

Editas Medicine | DEFA14A: Others

Apr 17 04:31

Editas Medicine | DEF 14A: Definitive information statements

Apr 17 04:31

Editas Medicine | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

Feb 29 06:31

Editas Medicine | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Feb 29 05:54

Editas Medicine | 8-K: Editas Medicine Announces Fourth Quarter and Full Year 2023 Results and Business Updates

Feb 28 20:07

Editas Medicine | 8-K: Current report

Dec 13, 2023 22:02

Editas Medicine | 8-K: Current report

Dec 12, 2023 05:23

Editas Medicine | 8-K: Current report

Nov 23, 2023 05:10

Editas Medicine | 8-K: Editas Medicine Announces Third Quarter 2023 Results and Business Updates

Nov 3, 2023 19:06

Editas Medicine | 8-K: Current report

Oct 11, 2023 04:05

Editas Medicine | 8-K: Editas Medicine Announces Second Quarter 2023 Results and Business Updates

Aug 2, 2023 19:16

Editas Medicine | 8-K: Current report

Jun 16, 2023 04:30

Editas Medicine | 8-K: Current report

Jun 9, 2023 18:01

Editas Medicine | 8-K: Current report

Jun 6, 2023 04:15

Editas Medicine | 8-K: Current report

May 18, 2023 04:30

Editas Medicine | 8-K: Current report

May 5, 2023 19:16

Editas Medicine | DEFA14A: Others

Apr 19, 2023 04:31

Editas Medicine | DEF 14A: Definitive proxy statements

Apr 19, 2023 04:30

Editas Medicine | 8-K: Current report

Apr 14, 2023 05:09